NCT05839444View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and Tolerability of BioPB-01 in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 27, 2023

Primary Completion Date

September 12, 2023

Study Completion Date

September 12, 2023

Conditions
Metabolic Syndrome
Interventions
OTHER

BioPB-01

2 sachets/day, one to be taken orally with (4±1 mins prior) at breakfast and one (4±1 mins prior) at dinner

OTHER

Placebo

2 sachets/day, one to be taken orally with (4±1 mins prior) at breakfast and one (4±1 mins prior) at dinner

Trial Locations (2)

390021

Aman Hospital and Research Center, Vadodara

422009

Lifecare Hospital, Nashik

All Listed Sponsors
lead

Vedic Lifesciences Pvt. Ltd.

INDUSTRY

NCT05839444 - A Clinical Study to Evaluate the Safety and Tolerability of BioPB-01 in Healthy Adults | Biotech Hunter | Biotech Hunter